Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

Other Abdominal pain (7%) Cough (1%) Fever (1%) Myalgia/Myositis/Myopathy/Myotoxicity (1%) Pain (~0.2%) Upper respiratory infection (4%) LUMIRACOXIB Trade name: Prexige (Novartis) Indications: Osteoarthritis Category: COX-2 selective inhibitor NSAID Half-life: 4 hours Clinically important, potentially hazardous interactions with: aspirin. other NSAIDs Reactions Skin Angioedema Exfoliative dermatitis Peripheral edema (2%) Stevens–Johnson syndrome Toxic epidermal necrolysis Other Abdominal pain (1%) Anaphylactoid reactions/Anaphylaxis Cough (2%) Hepatotoxicity Myalgia/Myositis/Myopathy/Myotoxicity (1.5%) LUTROPIN ALFA Trade name: Luveris (Merck) Indications: Infertility Category: Hormone modulator; Luteinizing hormone Half-life: ~14 hours Skin Edema Erythema Pruritus Rash (sic) Urticaria Vesiculation Xerosis Hair Hair – alopecia Other Abdominal pain (5–8%) Chills Fever Gynecomastia Injection-site edema Injection-site irritation Injection-site pain Reactions Injection-site reactions (3–4%) Upper respiratory infection (1–2%) LYCOPENE Scientific names: All-Trans-Lycopene; Psi-Psi-Carotene Trade and other common names: Carotenoid; Lyc-O-Mato; Lycovit (BASF) Category: Antioxidant Purported indications and other uses: Cancer (prevention), cardiovascular disease (prevention), asthma Half-life: N/A Note: Cooking increases bioavailability of lycopene. Major dietary sources are tomato paste, juice, and ketchup Reactions Skin Pigmentation (2003): Saldana Chaparro RS+, Ann Clin Biochem 40(Pt 3), 280 MAFENIDE* Trade name: Sulfamylon Indications: Second- and third-degree burns Category: Antiseptic; Sulfonamide Half-life: N/A Clinically important, potentially hazardous interactions with: None *Note: Mafenide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens–Johnson syndrome Reactions MAFENIDE 339 Skin Allergic reactions (sic) (1995): McKenna SR+, Burns 21(4), 310 Bullous dermatitis Burning Dermatitis (1993): Sanz de Galdeano C+, Contact Dermatitis 28(4), 249 (1992): Fernandez JC+, Contact Dermatitis 27(4), 262 Edema Erythema Excoriations Facial edema Pruritus (2.8%) (1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158 Rash (sic) (4.6%) (1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158 Other Anaphylactoid reactions/Anaphylaxis Application-site burning Death Hypersensitivity (1988): Perry AW+, J Burn Care Rehabil 9(2), 145 Pain (1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158 Porphyria

340 MAPROTILINE MAPROTILINE Trade names: Delgian; Ludiomil (Novartis); Maprostad; Melodil; Mirpan; Nono-Maprotiline; Psymion; Retinyl Indications: Depression, anxiety Category: Antidepressant, tetracyclic; Muscarinic antagonist Half-life: 27–58 hours Reactions Skin Acne (1988): Warnock JK+, Am J Psychiatry 145, 425 (1985): Oakley AM+, Aust N Z J Med 15, 256 (1982): Ponte CD, Am J Psychiatry 139, 141 Diaphoresis (3–8%) Edema Erythema Erythema multiforme (1990): Zukervar P+, J Toxicol Clin Exp 10, 169 Exanthems (1–9%) (1988): Warnock JK+, Am J Psychiatry 145, 425 Ichthyosis (1991): Niederauer HH+, Hautarzt (German) 42, 455 Petechiae Photosensitivity (1989): KochP+, Derm Beruf Umwelt (German) 37, 203 (1988): Warnock JK+, Am J Psychiatry 145, 425 Pruritus Purpura (1988): Warnock JK+, Am J Psychiatry 145, 425 Rash (sic) (>10%) Stevens–Johnson syndrome (1990): Zukervar P+, J Toxicol Clin Exp 10, 169 Urticaria (4%) (1988): Warnock JK+, Am J Psychiatry 145, 425 Vasculitis (1985): Oakley AM+, Aust N Z J Med 15, 256 Mucosal Sialorrhea Stomatitis Tongue black Xerostomia (20–40%) (1981): Rafaelsen OJ+, Acta Psychiatr Scand Suppl 290, 364 Hair Hair – alopecia (2000): Mercke Y+, Ann Clin Psychiatry 12, 35 (1991): Niederauer HH+, Hautarzt (German) 42, 455 Other Gynecomastia (

Other<br />

Abdominal pain (7%)<br />

Cough (1%)<br />

Fever (1%)<br />

Myalgia/Myositis/Myopathy/Myotoxicity (1%)<br />

Pain (~0.2%)<br />

Upper respiratory infection (4%)<br />

LUMIRACOXIB<br />

Trade name: Prexige (Novartis)<br />

Indications: Osteoarthritis<br />

Category: COX-2 selective inhibitor NSAID<br />

Half-life: 4 hours<br />

Clinically important, potentially hazardous interactions<br />

with: aspirin. other NSAIDs<br />

Reactions<br />

Skin<br />

Angioedema<br />

Exfoliative dermatitis<br />

Peripheral edema (2%)<br />

Stevens–Johnson syndrome<br />

Toxic epidermal necrolysis<br />

Other<br />

Abdominal pain (1%)<br />

Anaphylactoid reactions/Anaphylaxis<br />

Cough (2%)<br />

Hepatotoxicity<br />

Myalgia/Myositis/Myopathy/Myotoxicity (1.5%)<br />

LUTROPIN ALFA<br />

Trade name: Luveris (Merck)<br />

Indications: Infertility<br />

Category: Hormone modulator; Luteinizing hormone<br />

Half-life: ~14 hours<br />

Skin<br />

Edema<br />

Erythema<br />

Pruritus<br />

Rash (sic)<br />

Urticaria<br />

Vesiculation<br />

Xerosis<br />

Hair<br />

Hair – alopecia<br />

Other<br />

Abdominal pain (5–8%)<br />

Chills<br />

Fever<br />

Gynecomastia<br />

Injection-site edema<br />

Injection-site irritation<br />

Injection-site pain<br />

Reactions<br />

Injection-site reactions (3–4%)<br />

Upper respiratory infection (1–2%)<br />

LYCOPENE<br />

Scientific names: All-Trans-Lycopene; Psi-Psi-Carotene<br />

Trade <strong>and</strong> other common names: Carotenoid; Lyc-O-Mato;<br />

Lycovit (BASF)<br />

Category: Antioxidant<br />

Purported indications <strong>and</strong> other uses: Cancer (prevention),<br />

cardiovascular disease (prevention), asthma<br />

Half-life: N/A<br />

Note: Cooking increases bioavailability of lycopene. Major dietary<br />

sources are tomato paste, juice, <strong>and</strong> ketchup<br />

Reactions<br />

Skin<br />

Pigmentation<br />

(2003): Saldana Chaparro RS+, Ann Clin Biochem 40(Pt 3), 280<br />

MAFENIDE*<br />

Trade name: Sulfamylon<br />

Indications: Second- <strong>and</strong> third-degree burns<br />

Category: Antiseptic; Sulfonamide<br />

Half-life: N/A<br />

Clinically important, potentially hazardous interactions<br />

with: None<br />

*Note: Mafenide is a sulfonamide <strong>and</strong> can be absorbed systemically.<br />

Sulfonamides can produce severe, possibly fatal, reactions such as<br />

toxic epidermal necrolysis <strong>and</strong> Stevens–Johnson syndrome<br />

Reactions<br />

MAFENIDE 339<br />

Skin<br />

Allergic reactions (sic)<br />

(1995): McKenna SR+, Burns 21(4), 310<br />

Bullous dermatitis<br />

Burning<br />

Dermatitis<br />

(1993): Sanz de Galdeano C+, Contact Dermatitis 28(4), 249<br />

(1992): Fern<strong>and</strong>ez JC+, Contact Dermatitis 27(4), 262<br />

Edema<br />

Erythema<br />

Excoriations<br />

Facial edema<br />

Pruritus (2.8%)<br />

(1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158<br />

Rash (sic) (4.6%)<br />

(1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

Application-site burning<br />

Death<br />

Hypersensitivity<br />

(1988): Perry AW+, J Burn Care Rehabil 9(2), 145<br />

Pain<br />

(1993): Kucan JO+, J Burn Care Rehabil 14(2 Pt 1), 158<br />

Porphyria

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!